“When someone mentioned this, David got furious ... of brandy at his study at 1 a.m., at the end of one of Lazar’s frequent 15-hour work days. He spent one of those workdays last year at ...

Cyclacel Pharmaceuticals (NASDAQ:CYCC) said on Friday that it has entered into a securities purchase agreement with investor David Lazar, pursuant to which he agreed to purchase from the company ...

Investor David Lazar has come to the rescue of cash-strapped Cyclacel Pharmaceuticals, pumping $3 million into the biotech as well as taking on the top role and shaking up the board. The New ...

(CYCCP) a biopharmaceutical company focused on developing innovative cancer medicines announced on Friday that it has entered into a securities purchase agreement with investor David Lazar.

(NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") today announced that the Company entered into a securities purchase agreement (“Agreement”) with investor David Lazar (“Lazar ...

03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") today announced that the Company entered into a securities purchase agreement ...

Cyclacel Pharmaceuticals (CYCC) announced that the Company entered into a securities purchase agreement with investor David Lazar, pursuant to which he agreed to purchase from the Company ...

03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") today announced that the Company entered into a securities purchase agreement ...